The expression of KRAS shRNA in NPC cells resulted in a decrease in the levels of various critical cellular components and activities, including lipid raft-associated p85α–p110α–GTP-Rac1 complexes, Akt phosphorylation, glucose metabolism, and mitochondrial function. Here, KRAS is linked to nasopharyngeal carcinoma.